Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Recruiting · NCT07148297 · Registry updated 2025-08-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not stated | 2025-08-29 | NCT07148297 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Epiliquid Holding, Inc | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Epiliquid | Mendoza | Argentina | 2 |